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The transcriptome of embryonic and adult rat lateral ventricular choroid plexus, using
a combination of RNA-Sequencing and microarray data, was analyzed by functional
groups of influx transporters, particularly solute carrier (SLC) transporters. RNA-Seq
was performed at embryonic day (E) 15 and adult with additional data obtained at
intermediate ages from microarray analysis. The largest represented functional group
in the embryo was amino acid transporters (twelve) with expression levels 2–98 times
greater than in the adult. In contrast, in the adult only six amino acid transporters
were up-regulated compared to the embryo and at more modest enrichment levels
(<5-fold enrichment above E15). In E15 plexus five glucose transporters, in particular
Glut-1, and only one monocarboxylate transporter were enriched compared to the adult,
whereas only two glucose transporters but six monocarboxylate transporters in the adult
plexus were expressed at higher levels than in embryos. These results are compared
with earlier published physiological studies of amino acid and monocarboxylate
transport in developing rodents. This comparison shows correlation of high expression
of some transporters in the developing brain with higher amino acid transport
activity reported previously. Data for divalent metal transporters are also considered.
Immunohistochemistry of several transporters (e.g., Slc16a10, a thyroid hormone
transporter) gene products was carried out to confirm translational activity and to define
cellular distribution of the proteins. Overall the results show that there is substantial
expression of numerous influx transporters in the embryonic choroid plexus, many at
higher levels than in the adult. This, together with immunohistochemical evidence and
data from published physiological transport studies suggests that the choroid plexus
in embryonic brain plays a major role in supplying the developing brain with essential
nutrients.
Keywords: choroid plexus, brain development, amino acid transfer, protein transfer, brain barriers, cerebrospinal
fluid
Abbreviations: E, embryonic day; CSF, cerebrospinal fluid.
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Introduction
Influx transporters, active across interfaces between the blood
and the brain, are essential components of the mechanisms
that contribute to the composition and stability of the internal
environment of the brain, critical for normal brain function.
The main interfaces between these two compartments are the
blood-brain barrier across cerebral blood vessels and the blood-
cerebrospinal (CSF) barrier across the choroid plexuses within
the cerebral ventricles (Saunders et al., 2012). The transport
mechanisms in these interfaces have been well studied in the
adult brain (Davson and Segal, 1996; Brown et al., 2004;
Damkier et al., 2007, 2013; Abbott et al., 2010; Abbott and
Friedman, 2012) but relatively little is known about them during
gestation, although they are clearly important for normal brain
development and maturation. In addition, much of the research
focus has been on the blood-brain barrier itself rather than on
the transport properties of the choroid plexuses. Nevertheless, in
spite of this neglect, it seems that in the early developing brain the
choroid plexuses are probably a much more important portal of
entry into the brain than are the cerebral blood vessels (Johansson
et al., 2008). This is because the choroid plexuses develop to
being a substantial and functional tissue at a stage when the
brain is still poorly vascularised (Saunders et al., 2012, 2013). By
far the largest group of influx transporters is the solute carrier
gene series (SLCs), which currently comprises 52 families of 395
transporter genes (Hediger, 2013 and http://www.bioparadigms.
org/slc/intro.htm). These are particularly important for ion
exchange and amino acid and glucose delivery to the brain.
Until recently, very little was known about their expression and
function in the choroid plexuses of the developing brain. This
paper is the third in a series of combined RNA-Sequencing and
microarray analysis of transcriptome expression in developing
and adult choroid plexus, with a focus on the plexuses in the
lateral ventricles (Kratzer et al., 2013; Liddelow et al., 2013).
Here we give a comprehensive analysis of the expression of
solute carriers and other influx transporters in developing and
adult choroid plexus, with an emphasis on nutrient transporters
such as for glucose, amino acids and monocarboxylates and
compare these data with available published physiological data
on their transport activity in vivo. We also include results of
immunohistochemical staining of selected SLCs, which confirm
that their genes are translating to protein both in the embryo
and in the adult. The ion transporters thought to be important
for CSF secretion and its homeostasis, as well as brain interstitial
fluid have been dealt with in a previous paper (Liddelow
et al., 2013) together with the ABC/SLC transporters specifically
involved in neuroprotective CSF-to-blood eﬄux mechanisms
(Kratzer et al., 2013). Comparative data are also available from a
microarray study of mouse choroid plexus (Liddelow et al., 2012)
and an RNA-Seq study of non human primate choroid plexus (Ek
et al., 2015).
Materials and Methods
The animal tissue obtained for this study came from two earlier
published studies andmost methods were as previously described
(Kratzer et al., 2013; Liddelow et al., 2013).
Ethics Statement
Animal experiments inMelbourne were conducted in accordance
with Australian code of practice for the care and use of animals
for scientific purposes 7th Edition, published by the National
Health and Medical Research Council. All animal research
protocols were reviewed and approved by the University of
Melbourne Faculty of Medicine, Dentistry and Health Sciences
Animal Ethics Committee and registered under ID. Number
1011703. For experiments conducted in Lyon animal care and
procedures were in accordance with the guidelines approved by
the French ethical committee (decree 87-848), by the European
Community (directive 86-609-EEC).
Animal Husbandry
In Melbourne, timed-pregnant (embryonic day 15, E15) and
non-pregnant adult (6 week, 200–300g weight range) Sprague-
Dawley rats were used. These ages were chosen as they have been
previously shown to be appropriate for studies of the developing
lateral ventricular choroid plexus in rodents (Johansson et al.,
2006; Liddelow et al., 2012). Animals were supplied by the
Biological Research Facility at the University of Melbourne
(Victoria, Australia). For next generation RNA-Sequencing,
lateral ventricular choroid plexuses from E15 (n = 30) and
female adult (n = 30) rats were used. For immunohistochemistry
E15 (n = 3) and female adult (n = 3) lateral ventricular choroid
plexuses were dissected out and processed as described below.
For microarray experiments Sprague-Dawley rats (adult males,
pregnant time-dated females, or females with their litters) were
obtained from Janvier (Le Genest Saint Isle, France). All animals
were kept under similar conditions in standard cages, with free
access to food and tap water under a controlled environment
(12 h day/light cycles).
Collection of Lateral Ventricular Choroid Plexus
The procedure for collection of choroid plexus tissues has
previously been described (Liddelow et al., 2012; Kratzer et al.,
2013). Briefly, animals were killed by an overdose of inhaled
isoflurane (Veterinary Companies of Australia) and brains
dissected out under ice-cold RNase-free phosphate buffered
saline (PBS, pH 7.3). Both left and right lateral ventricular
choroid plexuses were carefully dissected out and placed in fresh
ice-cold RNase-free PBS. All steps were performed under RNase-
free conditions. The collected tissues were snap-frozen in liquid
nitrogen and kept at−80◦C until used.
For Illumina RNA-Sequencing, lateral ventricular choroid
plexuses from E15 (n = 30) and adult (n = 30) rats
were used (three pooled samples of ten plexuses at each
age). Total RNA was extracted using the RNeasy Mini Kit,
Qiashredder columns and gDNA removal columns (Qiagen,
Valencia, CA, USA) according to standard supplier protocols. All
RNA samples were quantified using a NanoDrop ND-1000 UV-
VIS spectrophotometer (Thermo Scientific, Wilmington, DE,
USA) and quality checked with the Agilent 2100 Bioanalyzer
(Agilent Technologies, Palo Alto, CA, USA). Plexuses were
pooled (n = 10 animals) and centrifuged at 1000 rpm for 30 s,
excess PBS removed, snap frozen in liquid nitrogen and stored
at −80◦C. For Affymetrix microarrays, choroid plexuses were
pooled from 3 to 5 animals. Total RNA was isolated from two
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pools of choroid plexuses sampled from E19, P2, or adult rats
using the RNeasy R© Micro Kit (Qiagen, Valencia, CA, USA), and
DNase-treated according to the manufacturer’s protocol.
The choroid plexus consists of epithelium as well as blood
vessels, neural innervation and mesenchymal stroma. However,
the epithelium is the predominant cell type, suggested to
represent up to 90% of the plexus tissue (Keep and Jones, 1990;
Liddelow et al., 2012). In this study lateral ventricular choroid
plexus was taken in toto.
Illumina Next Generation RNA Sequencing
RNA Sequencing was performed at the Australian Genome
Research Facility (Melbourne, VIC, Australia). A cDNA library
was prepared from 10µg of total RNA using the mRNA-
Seq Sample Preparation Kit (Illumina, San Diego, CA, USA)
according to standard manufacturer protocol. Quality of the
library was verified using a DNA 1000 chip using the Agilent
2100 Bioanalyzer (Agilent).The library was subjected to 100 bp
single end read cycles of sequencing on an Illumina HiSeq
2000 sequencer as per manufacturer protocol. Cluster generation
was performed on a c-Bot (Illumina) with a single read cluster
generation kit.
Data Analysis
Short reads were trimmed to remove ambiguous bases from
the start and segments with low quality scores from the end,
as indicated by the ascii character “B” in Illumina 1.5 phred
score encoding. Trimmed reads were mapped with Bowtie
version 0.12.7 (Langmead et al., 2009) to the Ensembl (Hubbard
et al., 2009) rat genome, release 61. Reads that did not map
uniquely were discarded. The number of reads mapped to
nuclear genes was determined with HTSeq (Anders, 2010)
version 0.4.7p4, using the default “union” counting option.
Differential expression between the adult and embryonic samples
was detected using an exact test in the Bioconductor (Gentleman
et al., 2004) edgeR package, version 2.4.0 (Robinson et al., 2010),
with common dispersion used to estimate variance between
samples. Genes considered significantly differentially expressed
were those with a p-value of less than 0.05 after Benjamini-
Hochberg false discovery rate correction. All fold changes
during development were calculated from these normalized data.
However, where appropriate we have also included raw counts
for each transcript. As noted in the legends to relevant tables
(Tables 4–6) ratios for individual genes calculated from raw
counts may not correspond to the fold changes (as shown in
the tables) calculated from normalized data. We have included
both the normalized fold changes and raw cell counts to enable
the reader to see both relative expression changes throughout
development, as well as the absolute abundance of each transcript
at an individual age. A combination of gene ontology annotation
and manual curation was used to select genes encoding proteins
with integral transporter function. Gene ontology descriptions
for rat were downloaded from Biomart (Hubbard et al., 2009),
and genes with “transport” mentioned in their gene ontology
description were selected. Genes of interest were then extracted
from this list. For initial analysis genes with>100 sequence reads
and age-related fold changes (FC) > 2.0 (log2FC > 1.0) were
collated and are summarized in Tables 4–6, and Supplementary
Tables S1–S3; this level of gene expression was taken as likely
to be functionally significant. For identification of the presence
of a particular gene a lower cut-off of 10 sequence reads was
used; these are also included in Tables 4–6. Illumina RNA
sequencing data have been deposited with the Gene Expression
Omnibus (http://www.ncbi.nlm.nih.gov/geo/) under accession
code GSE44072.
Microarray
As previously described (Kratzer et al., 2013) microarray
analysis was performed using a high-density oligonucleotide
array (GeneChip Rat Genome 230 2.0 array, Affymetrix,
Santa Clara, CA, USA). Total RNA (100 ng) was amplified
and biotin-labeled using GeneChip R© 3′ IVT Express target
labeling and control reagents according to Affymetrix protocol
(http://www.affymetrix.com). Before amplification, all samples
were spiked with synthetic mRNAs at different concentrations,
which were used as positive controls to ascertain the quality
of the process. Biotinylated antisense cRNA for microarray
hybridization was prepared. After final purification using
magnetic beads, cRNAs were quantified using a NanoDrop and
quality checked with Agilent 2100 Bioanalyzer. Hybridization
was performed according to the Affymetrix protocol. Briefly,
10µg of labeled cRNA was fragmented and denaturated in
hybridization buffer, then hybridized on the chip for 16 h at
45◦C with constant mixing by rotation at 60 rpm in a Genechip
hybridization oven 640 (Affymetrix). After hybridization, arrays
were washed and stained with streptavidin-phycoerythrin
(GeneChip R© Hybridization Wash and Stain Kit) in a fluidic
station 450 (Affymetrix) according to the manufacturer’s
instruction. The arrays were read with a confocal laser (Genechip
scanner 3000, Affymetrix). CEL files summarizing the probe cell
intensity data were generated using the Affymetrix GeneChip
Command Console (AGCC) software 3.0. Data were normalized
with Affymetrix Expression Console software using MAS5
statistical algorithm. Data have been deposited into the Gene
Expression Omnibus repository (http://www.ncbi.nlm.nih.gov/
geo) under accession number GSE44056.
Immunohistochemistry
Sagittal sections through E15 and adult rat brain including
lateral choroid plexus were selected from the collection of
rat tissue at the Faculty of Health and Medical Sciences,
University of Copenhagen and used for immunohistochemical
detection of SLC16a10, Slc38a5 (SNAT5), Slc4a1, Slc11a1
(NRAMP), Slc39a4 (ZIP4), and Slc1a3 (EAAT1). Sections were
deparaffinised in xylene, rehydrated through graded alcohols
followed by treatments in 0.5% hydrogen peroxide in methanol
for 15min and rinsing in TRIS buffered saline (TBS) as described
previously (Liddelow et al., 2012). Following removal of non-
specific binding by incubation for 30min with blocking buffer
(ChemMate antibody diluent S2022, DakoCytomation, Glostrup,
Denmark) at room temperature sections were incubated in
primary antibodies as listed in Table 1.
After overnight incubation sections were washed in TBS and
incubated for 30min in EnVisionTM+ System/HRP (DAKO),
K5007, for rabbit antibodies and RPN1025 from GE Healthcare
for donkey anti-goat antibodies and then Vector: Vectastain
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TABLE 1 | List of primary antibodies used for immunohistochemistry.
Primary antibody Host IgG Dilution Retrieval Producer Code number
Slc16a10 (MCT10) Rabbit 1:20 M6 Abcam Ab121519
Slc38a5 (SNAT5) Goat 1:150 - Santa Cruz Sc-50682
Slc4a1 (AE1) Rabbit 1:100 - Proteintech 18566-1-AP
Slc11a1 (NRAMP) Rabbit 1:70 - Santa Cruz Sc-20113
Slc1a3 (EAAT1) Rabbit 1:600 - Abcam Ab416
Slc5a5 (NIS) Rabbit 1:200 - Proteintech 24324-1-AP
SLC 39a4 (ZIP4) Rabbit 1:200 - Proteintech 20625-1-AP
RTU elite ABC reagent PK 7100. This was followed by
6min incubation with DAB-chromogen solution (DAKO) and
counterstaining with Mayer’s haematoxylin, dehydrated and
mounted with DPX. Control sections contained no primary
antibodies and were always blank.
Photography and Image Preparation
Digitized images were obtained using an Olympus DP70 camera
housing (Olympus, Tokyo, Japan) attached to an Olympus BX50
light microscope (Olympus). A10× eyepiece and 40× objective
lens were used. Raw image files were process in Adobe Photoshop
CS5 R© (Adobe R© Systems, San Jose, CA, USA). The brightness
and curve functions were used to obtain images with background
close to white. There was no other manipulation of images.
Results
Solute Carriers (SLCs) Identified by
RNA-Sequencing and Microarray
Examination of the whole transcriptome data set from RNA-
Sequencing showed 48 families of the 52 known SLC families
(Hediger, 2013) and 64% of transcripts in these families
were identifiable at functionally significant levels of expression
(>100 transcript reads, Figure 1, Supplementary Table S1). The
distribution of genes at the two ages that showed increased,
decreased or unchanged expression is illustrated in Figure 2. For
each SLC family the distribution of gene expression in embryonic
and adult choroid plexus is shown in Figure 3.
The Slc genes that were expressed at a higher level (>2 fold)
in the embryonic choroid plexus than in the adult are listed in
Table 2; microarray data from E19 and P2 are also shown. The
Slc genes that were expressed at a higher level (>2 fold) in the
adult plexus are shown in Table 3; data comparing adult with
E19 and P2, from microarray, are also shown. The main focus
of this report is the Slc transporter genes involved in nutrient
transport into CSF, particularly amino acids, monocarboxylates
and glucose.
In the present study the numerous members of the SLC
families of transport proteins that were present in the lateral
ventricular choroid plexus at E15 and in the adult had strikingly
different patterns of gene expression at these two ages: of 250 total
genes identified by RNA sequencing (Supplementary Table S2),
81 were expressed at higher levels at E15 (Supplementary Table
S2 and Table 2). Developing-to-adult fold change differences
between E19 and P2 were modest, apart from Slc7a11, Slc7a1,
and Slc6a15, suggesting that birth is not a key milestone
for developmental changes in the choroidal Slc transcriptome.
A number of genes such as Slc4a1, Slc2a3, Slc11a1 had
strikingly higher E15/Adult fold change than E19-P2/Adult
fold changes. This suggests very specific choroidal function for
brain development at the early stages of gestation. 107 genes
were up-regulated in the adult (Supplementary Table S3 and
Table 3). For these genes the array analysis shows that the
E19/Adult and P2/Adult fold changes were modest and lower
than E15/Adult fold changes for most of these genes, indicating
that the choroid plexus starts to acquire its “adult” phenotype
early in development, i.e., at late prenatal stages in the rat. Finally,
62 genes showed no difference in expression level between the
ages (Supplementary Table S3), indicating the early maturity and
life-long duration of different choroidal functions, in addition
to early development-specific functions assumed from the E15
specific genes identified. Many fewer Slc transporter genes have
been identified at the blood-brain barrier (Daneman et al., 2010—
supplementary material) of about 56 transcripts, which is around
a quarter of that identified in this choroid plexus study. This
finding supports the previously suggested proposition that in the
developing brain the choroid plexus is the main route of entry
for amino acid and ion transport and other molecules essential
for brain development (Johansson et al., 2008).
Glucose and Monocarboxylate Transporters
Table 4 lists the glucose and monocarboxylate transporters
differentially regulated in the embryo and in the adult with
a fold change (FC) of two or more. Slc5a10 (sodium/glucose
co-transporter) was expressed only in the embryonic plexus,
but at a low copy number. Gene array shows that it was still
expressed at E19, but disappeared after birth. The number
of glucose transporters expressed at a higher level in the
embryo was strikingly more than those higher in the adult (five
compared to two, note that Klf15 is a regulator of GLUT4, not a
transporter itself, Gray et al., 2002). The converse was the case for
monocarboxylate transporters; there was only one in the embryo,
but 6 in the adult.
Slc2a3 (GLUT3) was only detected in the embryo using RNA-
Seq, but in microarray data was expressed at similar levels in
the adult (ratio of 0.7–0.8). However, the transcript numbers in
RNA-Seq were very low, so this result is of dubious functional
significance. Three other glucose transporters (Slc2a4, Slc2a5,
Slc45a1) had transcript numbers <100 at both ages and were
not detected in microarray, so these genes are unlikely to
be contributing to glucose transport via the choroid plexuses.
More relevant is GLUT1 (Slc2a1) which is well expressed in
embryonic and E19 fetal choroid plexus relative to P2 or adult.
This transporter is crucial for glucose delivery to the brain.
Its expression in the developing brain choroid plexus argues
for a specific role of the plexus in nutrient transport at these
ages. Amongst monocarboxylate transporters the same single one
(Slc10a16) was increased in the developing choroid plexus in
both RNA-Seq andmicroarray results. Themost highly expressed
of all the monocarboxylate transporters (in terms of transcript
numbers) was Slc16a2, at a slightly higher (2.1 fold) level in
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FIGURE 1 | Slc transporter genes identified in rat lateral
ventricular choroid plexus. Expression of SLC family class transcripts
in the rat lateral ventricular choroid plexus regardless of age, as
determined by RNA sequencing. The 52 known functional groups of
SLC transporters (Hediger, 2013) are shown on the left. Data are
expressed as percentage total of each family of transporters (transcript
number > 10)—for example, 100% of proton-coupled metal ion
transporters (SLC11 family) are present in the rat lateral ventricular
choroid plexus, whereas no steroid-derived molecule transporters
(SLC51 family) were detected.
the adult than in the embryo; this transporter was not detected
in microarray, possibly because the probe was not a good
match. Slc16a8 was expressed at a high level in adult plexus,
but expression was <100 transcript counts in the embryo in
the RNA-Seq analysis and was also not detected in microarray.
Three other monocarboxylate transporters were expressed at
high level in adult plexus in both microarray and RNA-Seq
(Tables 3, 4).
Amino Acid Transporters
There were twice as many genes coding for amino acid
transporters in the embryonic choroid plexus expressed at a
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FIGURE 2 | (A) Scatter plot comparing log2(FPKM), i.e., fragment count
per kilobase of exonic length per million reads mapped, for all
transcripts detected by RNA sequencing of the rat lateral ventricular
choroid plexus, averaged across replicates from embryonic day 15 (E15)
and adult. Red points show transcripts with higher expression at E15
(greater than 2-fold) while blue points are those with higher expression
in the adult. FPKM was estimated using a standard ArrayStar pipeline
(http://www.dnastar.com/t-help-arraystar.aspx). There is a greater number of
transcripts enriched in the embryo. (B) Parallel coordinate plot of
change in average expression (log2(FPKM)) of SLC transporters in E15
and Adult lateral ventricular choroid plexus. Lines connect the same
transcript present at both ages. (C) Heat map of average expression
(log2(FPKM)) for SLC transporters. Red depicts high expression values,
blue low expression. Gray depicts transcripts that were not detected at
one age. The expression level of SLC transporters was much higher at
E15—as shown by more red expression data.
higher level than in the adult (12 compared to 6, Table 5).
The level of expression of these transporters in the embryo
was also generally higher; thus in the embryo nine of the
transporters were expressed at >5 fold compared to adult,
whereas in the adult only one transporter gene was expressed
>5 fold compared to the embryo. The microarray results were
generally consistent with those from RNA-Seq (Tables 2, 4,
5). For both methods the expression levels of Slc7a11, Slc7a1,
Slc6a6, and Slc6a15 were notably high in the embryonic plexus.
For two genes (Slc3a1, Slc7a10) the expression levels were
higher in the adult with RNA-Seq, but lower with microarray
(Tables 3, 5).
Divalent Metal Transporters
It has been known for many years that zinc is important
for normal brain development and for function in the adult
(Sandstead, 1985; Marger et al., 2014; Tyszka-Czochara et al.,
2014). In the present study there were 4 zinc transporter genes
that were expressed at a higher level in embryonic choroid plexus
than in the adult in the fold range of 2.5–44 (Table 6). In the adult
there weremore up-regulated zinc transporter genes (6), but their
expression level was generally much lower (2.7–12 fold). Both of
the major zinc transporter families (Slc30, ZnT, and Slc39, ZIP)
are represented in our dataset. The members of the two families
function in opposite directions, thus maintaining cellular zinc
homeostasis. ZnT proteins of Slc30 genes eﬄux zinc whereas ZIP
proteins function to increase zinc uptake when cellular zinc is
depleted (Marger et al., 2014; Tepaamorndech et al., 2014). Ten
Slc30 genes were identified in the present study (two higher in
the embryo, Slc30a2, 44 FC; Slc30a10, 35 FC and four in the
adult, Slc30a3-6, with only modest 2.7–4.5 FC). Ten Slc39 genes
were identified; Slc39a8was 37 FC higher in embryo. Three other
members, Slc39a1, Slc39a12, and Slc39a13 (FC 12, 12 and 3.9
respectively), were higher in adult (Table 6).
The transferrin gene, Tf, was expressed in terms of transcript
numbers at a high level in both the embryo and adult
(Table 6), but much higher in the latter (183 fold), with a
continuous pre-and post natal increase from embryo to adult
stages. The transferrin receptor was expressed at a higher
level in embryonic choroid plexus (3.1 fold) with intermediate
expression levels at the perinatal stage of development. As
indicated in Table 6 several other iron carriers were expressed
at a higher level in the embryo than in the adult: sideroflexin-
1, Sfxn1 (14 fold), ferritin light chain 1-like (LOC100360087),
3.6 fold), and this difference in expression was maintained
perinatally.
Slc11a1 was expressed at much higher levels in the embryonic
choroid plexus than in the adult (8.9 fold), and at still higher
level at birth, while Slc11a2 (DMT1) was found expressed at
a similar level at all ages examined by both RNA-Seq and
microarray approaches (Table 6). Several members of these SLC
families of divalent metal transporters have been implicated in
iron and manganese transport. Their expression in developing
choroid plexus correlates with the higher uptake of manganese by
postnatal choroid plexus cells in vitro as shown by Schmitt et al.
(2011), and is discussed further below.
Immunohistochemistry
Immunohistochemical investigations of the distribution of some
eﬄux transporter proteins selected from the gene expression
data included five enriched in the fetus: SLC 16a10 (TAT1), SLC
38a5 (SNAT5), SLC 4a1 (AE1), SLC 11a1 (NRAMP), SLC 1a3
(EAAT1), one enriched in the adult: SLC 5a5 (NIS) and one
expressed at a low level in both fetal and adult choroid plexus:
SLC 39a4 (ZIP4).
The seven tested antibodies resulted in 3 different
patterns of immunoreactivity in E15 plexus epithelial cells
(“differential immunoreactivity, regional distribution-type,”
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FIGURE 3 | Slc transporter genes identified in rat lateral ventricular
choroid plexus. Expression of SLC family class transcripts in the embryonic
and adult lateral ventricular choroid plexus as determined by RNA
sequencing. Data are expressed as percentage total of each family of
transporters. The 52 known functional groups of SLC transporters (Hediger,
2013) are shown on the left. The horizontal bars show the percentage of total
number of members of each group identified “Enriched” refers to transcripts
with greater than 2-fold expression in one age over the other, while “no
change” refers to transcripts with similar expression at both ages. A
transcript was considered absent in the choroid plexus if no single copy of
transcript was detected (while those with “below threshold” had raw count
values below 10). A transcript was considered absent in the rat if no
annotation was found in the online ensemble database
(http://www.ensembl.org/Rattus_norvegicus).
“strong immunoreactivity, uniform distribution-type,” “weak
immunoreactivity, uniform distribution-type”) and in 2
different patterns of immunoreactivity in adult plexus
epithelial cells (“weak or lack of immunoreactivity,” “strong
immunoreactivity”). Representative micrographs from the 5
different patterns of immunoreactivity are shown in Figure 4.
SLC 16a10
An example of “differential immunoreactivity, regional
distribution-type” is shown in E15 and of “weak or lack
of immunoreactivity” is presented in adult plexus. The
embryonic plexus epithelial cell layer in the “plexus-fold” next
to the ganglionic eminence but opposite to the developing
hippocampus showed a stronger immunostaining than
the “plexus-fold” facing the hippocampus (Figure 4A).
At high magnification the prominent reactivity in the
epithelial cell layer facing the ganglionic eminence was
shown to be due to a combination of a marked fine granular
reactivity in apical cytoplasm and along both apical and
basolateral cell membranes, which were particularly strongly
immunostained (arrowheads in Figure 4A1). In contrast the
epithelial cell layer facing the hippocampus showed a more
uniform immunoreactivity both in cytoplasm and along cell
membranes. Adult choroid plexus epithelial cells exhibited
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TABLE 2 | Expression and function of solute carrier (Slc) transcripts that were enriched in lateral ventricular choroid plexus of rat E15 and E19 embryos
and P2 neonates compared to adult.
Gene ID Protein Transport function Ref. E15/A E19/A (E19/P2) P2/A
Slc16a10 MCT10 Aromatic AAs, T3, T4 1 E P (2.1) P
Slc38a5 SN2, JM24, Na+-dependent AAs 2 E P (0.6) P
Slc43a3 EEG1 Na+-independent, L-like AAs 2 E − −
Slc39a10 ZIP10 Zn2+ E − −
Slc35f1 FLJ13018 Nucleoside-sugar 60 − −
Slc4a1 AE1, CD233 Anion (Cl−-HCO3 exchange) 6, 7 59 6.4 3.4
Heph Hephaestin Fe2+, Cu2+ E 6.1 6.3
Slc7a11 xCT Cysteine, glutamate 2, 5 44 24 5.4
Slc30a2 ZnT2 Zn2+ 9 E P (1.7) P
Slc14a2_v1 UTR, UT2 Urea transport 39 − −
Slc39a8 ZIP8 Zn2+, Cd2+ 9 37 P (1.3) P
Slc6a4 SERT Na-dependent 5HT transport 35 − −
Slc30a10* ZnT10 Zn2+ E − −
Slc43a1 LAT3 Neutral AAs (phenylalanine) 2 E P (0.8) P
Slc35f2 FLJ13018 Nucleotides into Golgi 19 − −
Slc7a1 CAT1 Cationic AAs (arginine, lysine) 2, 5 16 11 3.7
Slc8a3 NCX3 Na+/Ca2+ exchanger 15 − −
Slc38a1 NAT2 Glutamine (Na+-dependent) 3 15 P (1.0) P
Slc6a6 TAUT Taurine, β-alanine 2, 5 14 6.9 6.1
Sfxn1 Sideroflexin 1 Fe2+ 14 8.1 7.2
Slc6a15 BOAT2 Neutral AAs 2, 5 14 9.8 4.3
Slc22a6* OAT1, NKT Organic anions (Na+-dependent), kynurenic acid, Hg2+ 14 − −
Slc23a1 SVCT1 Na dependent ascorbic acid 13 − −
Slc39a11 ZIP11 Zn2+ transporter 12 − −
Slc2a3 GLUT3 Glucose transporter 11 0.8 0.7
Slc5a7 CHT Choline, Na+/glucose co-transport 11 − −
Slc17a6 VGLUT2 Glutamate 3 9.1 − −
Slc7a3 CAT3 Cationic amino acids 2, 5 9.1 P (1.0) P
Slc11a1 NRAMP Fe2+, Mn2+, arginine 10, 11 E 1.6 1.4
Slc8a1 NCX1 Na+/Ca2+ exchanger 8.1 − −
Slc27a6 FATP6 Long chain fatty acids 7.8 − −
Slc45a3 PROSTEIN Putative sugar transporter 6.6 − −
Slc34a2 NaPi-IIb PO3−4 (Na
+-dependent) 6.1 P (1.4) P
Slc19a3 THTR2 Thiamine 6.0 − −
Slco2a1 PGT, OATP2A1 Prostaglandin D2, E1, E2 and F2A, organic anions 5.7 P (1.7) P
Slc38a11 − Na+-dependent AA/proton antiporter (putative) 5.3 − −
Slc5a8 SMCT1 Monocarboxylate transporter 5.2 − −
Slc16a14 MCT14 Monocarboxylate transporter 5.2 − −
Slc38a4 ATA3 Acidic and neutral AAs 2. 3, 5 5.2 − −
Slc35d2 HFRC Nucleotide sugars 5.1 − −
Slc1a4 SATT Glutamate, neutral AAsalanine, serine, cysteine, threonine 3, 4 5.1 − −
Slc1a3 GLU-T Glutamate, neutral AAs 3, 4 4.5 3.3 2.8
Slc6a13 GAT3 GABA transporter 8 4.4 P (0.4) P
Slc9a5 NHE5 Na+/ H+ exchanger 6, 7 4.4 P (0.9) P
Slc37a2 SPX2 Glucose-6-phosphate antiporter 4.2 − −
Slc4a4 NBC1 Electrogenic NaHCO3 6, 7 3.9 − −
LOC100360087 Ferritin Light Chain, Flt1-like Fe3+ storage 3.6 2.4 1.7
Slc22a2 OCT2 Organic cations, anions, zwitterions 3.4 − −
Slc29a2 ENT2 Nucleosides 3.2 1.2 1.1
Trfr TFR Transferrin receptor 3.1 0.5 0.6
(Continued)
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TABLE 2 | Continued
Gene ID Protein Transport function Ref. E15/A E19/A (E19/P2) P2/A
Slc2a1 GLUT1 Glucose 3.0 1.9 0.9
Slc27a3 FATP3 Long-chain fatty acids 2.9 2.3 2.9
Slc24a6 − Na+/Li2+/Ca2+ exchanger 2.8 1.2 1.2
Slc7a2 CAT2 Low affinity cationic AAs 2.7 P −
Slc4a3 AE3 Anion exchange 6, 7 2.7 0.6 0.8
Slc25a27 UCP4 Mitochondrial uncoupling protein 2.7 − −
Slc38a7 SNAT7 Putative Na+-coupled neutral AAs 2.7 − −
Slc22a15 FLIPT1 Organic cations, anions, zwitterions 2.6 2.1 1.8
Slc35e1 FLJ14251 Nucleotide sugars 2.5 1.2 0.9
Slc22a9 OAT7 Organic anions 2.5 − −
Slc14a1 UT-B1-B2 Urea 2.4 − −
Slc22a23 − Organic cations, anions, zwitterions 2.4 1.7 1.0
Slc43a2 LAT4 Large neutral AAs 2.4 1.3 1.4
Slco2b1 OATP2B1 Organic anions 2.4 2.3 2.3
Slc29a3 ENT3 Nucleosides 2.1 0.8 0.7
Slc1a5 ASCT2 Neutral AAs 3,4 2.1 0.8 0.7
E15 from RNA-Seq (Only transcripts with fold change (FC) > 2.0, p value < 0.05, and raw Illumina counts >100 are shown; actual counts are in Tables 4–6). E19 and P2 data from
microarray. -: not on the microarray or not detected. P indicates that a signal was detected in E19 or P2, but was below background level in adult samples. The fold change between
E19 and P2 is shown in parenthesis. E indicates that a signal was detected in E15 but was below threshold in adult samples. *transporter suggested to be involved in efflux of molecules
out of the CSF. A comprehensive list with gene IDs and gene descriptions and statistical data is in Supplementary Table S2 of Supplementary Material. Some genes that are not Slc
but play a role in blood-CSF transport of metals, have also been added to this table. Ref indicates publications with information on amino acid transport: 1Porterfield and Hendrick
(1992); 2Lefauconnier and Trouvé (1983); 3Al-Sarraf et al. (1997); 4Braun et al. (1980); 5Cornford et al. (1982); 6Brown et al. (2004); Adult 7Damkier et al. (2007) Adult, 8Al-Sarraf (2002);
9Chowanadisai et al. (2005); 10Moos and Morgan (1998); 11Morgan and Moos (2002).
virtually no immunostaining of either membranes or cytoplasm
(Figure 4B).
SLC1a3
This protein showed an example of “strong immunoreactivity,”
uniform distribution type at E15 and of “weak or lack of
immunoreactivity” in adult plexus. Both embryonic plexus
epithelial cell layers of the “plexus-fold”—the leaflet next to the
ganglionic eminence and the other next to the developing
hippocampus - showed a strong uniform cytoplasmic
immunostaining (Figure 4C). At high magnification the
prominent reactivity was shown to be due to a combination
of a marked fine granular reactivity in apical cytoplasm and
along both apical and basolateral cell membranes, which were
particularly strongly immunostained (arrowheads in Figure 4C1)
comparable to those stained for SLC16a10 in the plexus fold
next to the ganglionic eminence shown in Figure 4A1. Adult
choroid plexus epithelial cells showed virtually no cytoplasmic
immunostaining and a lack of apical and basolateral cell
membrane immunoreactivity (Figure 4D).
SLC5a5
Shown as an example of “weak immunoreactivity,” uniform
distribution at E15 and of “strong immunoreactivity” in adult
plexus. Embryonic plexus epithelial cells showed no cytoplasmic
reactivity and no immunostaining of the apical cell membrane
in marked contrast to the adjacent strongly stained CSF-
hippocampal interface (Figure 4E). A weak basolateral cell
membrane staining of plexus epithelial cells could be identified
at high magnification (arrowheads in Figure 4E1). Adult choroid
plexus exhibited a uniform fine and coarse granular cytoplasmic
staining of most epithelial cells (open arrows in Figure 4F) and a
distinct apical membrane staining (arrowheads in Figure 4F).
SLC39a4 (ZIP4), SLC38a5 (SNAT5), SLC4a1 (AE1),
SLC11a1 (NRAMP)
Following immunostaining for SLC39a4 plexus epithelial cells
were characterized by “weak immunoreactivity,” uniformly
distributed in both E15 and adult plexus, whereas staining for
SLC38a5, SLC4a1, and SLC11a1 resulted in immunoreactivity of
the uniform distribution-type, however stronger along the basal
and basolateral cell membrane in E15, and very little cytoplasmic
staining and virtually no basolateral or apical membrane staining
in adult plexus apart from SLC38a5 which showed a patchy
immunostaining of the apical cell membrane (data not shown).
Discussion
All but four of the 52 known families of SCL transporters
were represented in the dataset from RNA sequencing of lateral
ventricular choroid plexuses in the rat embryo (E15) and in
the adult (Supplementary Table S1). Of the 389 individual
SCLs, 64% had transcript numbers above the threshold taken to
indicate likely functional significance (>100 sequence reads). 81
of these were expressed 2 fold higher or more in the embryonic
plexus compared to the adult, 107 were expressed higher in the
adult and 62 were expressed at similar levels at the two ages.
Some genes were identifiable with transcript counts of 10–100,
but thought less likely to be of functional significance; they
have nonetheless been included in Tables 4–6. The results for
Frontiers in Neuroscience | www.frontiersin.org 9 April 2015 | Volume 9 | Article 123
Saunders et al. Developing choroid plexus influx mechanisms
TABLE 3 | Expression and function of solute carrier (Slc) transcripts that were enriched in lateral ventricular choroid plexus of adult rats compared to E15
RNA-Seq) and E19 and P2 (microarray).
Gene ID Protein Transport function Distribution** A/E15 A/E19 A/P2
Tf Transferrin Fe2+ ubiquitous 183 5.1 2.3
Lcn2 Lipocalin 2 Fe2+ ubiquitous 55 6.2 1.0
Slc16a8 MCT3 Monocarboxylate brain 55 − −
Slc6a20 XTRP3 Na+- and Cl−-dependent AAs apex epithelial cells (gut) 24 1.0 1.1
Slc29a4 ENT4 monoamines brain 19 − −
Slco1c1 OATP1C1 organic anions, T4, T3 BBB 18 5.3 3.2
Slc9a2 NHE2 Sodium/hydrogen exchanger BBB 18 a 1.3
Slc21a4 OAT-K1 organic anions not brain or CP 14 − −
Slc44a3 CTL3 Choline not brain or CP 14 − −
Slc25a31 PHC ADP/ATP brain 14 − −
Slc24a3 NCKX3 Na/K/Ca exchanger CP* 12 a 2.3
Slc39a12 ZIP12 zinc brain 12 − −
Slc19a2 ThTr1 thiamine ubiquitous 11 3.6 2.3
Slc28a3 CNT3 purine, pyrimidine nucleosides not brain or CP 10 − −
Slc17a8 VGLUT3 Vesicular glutamate brain 8.9 − −
Slc12a3 NCC K+/Cl2 co-transporter CP* 7.5 − −
Slc12a2 NKCC1 Na+/K+/Cl−2 CP* 7.5 1.6 1.4
Slc5a11 SMIT2 Myoinositol brain 6.6 − −
Cp Ceruloplasmin Cu2+ binding ubiquitous 6.2 0.6 0.3
Slc22a25 UST6 unknown liver 6.0 1.9 1.0
Slc24a5 NCKX5 Na+/Ca2+ /K+ coupled brain 5.8 1.1 1.4
Slc17a9 VNUT vesicular nucleotide brain 5.8 − −
Slc4a5 NBCe2 Electrogenic NaHCO3 cotransporter CP* 5.4 − −
Slc35d1 UGTREL7 UDP-glucuronic acid/UDP-N-acetylgalactosamine ubiquitous 5.2 − −
Slc22a5 OCTN2 zwitterions, organic cations not brain or CP 5.1 1.8 1.4
Slc2a12 GLUT12 glucose not brain or CP 5.1 − −
Slc31a1 CTR1 copper ubiquitous 4.7 1.3 1.1
Slc35a1 CST CMP-sialic acid transporter ubiquitous 4.5 2.0 1.5
Slc6a8 CT1 Na- and Cl-dependent creatine brain 4.5 2.0 1.8
Slc3a1 rBAT Neutral and basic amino acids not brain or CP 4.5 0.6 0.3
Slc30a4 ZNT4 Zinc brain 4.5 1.3 1.1
Slc23a2 SVCT2 ascorbic acid epithelial tissues 4.2 − −
Slc7a4 CAT4 cationic amino acids brain 4.0 1.4 1.5
Slc39a13 ZIP13 Zinc ubiquitous 3.9 2.3 1.7
Slc17a5 SIALIN acidic sugar ubiquitous 3.8 1.5 1.6
Slc25a16 GDC Graves disease carrier protein brain 3.8 1.9 1.5
Slc10a6 SOAT organic anions, primarily sulphated steroids not brain or CP 3.8 NOA NOA
Slc30a3 ZNT3 Zinc brain synaptic vesicles 3.8 2.6 1.9
Slc16a12 MCT12 proton-linked monoarboxylate not brain or CP 3.8 − −
Slc16a6 MCT7 monocarboxylate brain 3.7 1.9 1.7
Slc25a29 ORNT3 Mitochondrial carnitine/acylcarnitine brain 3.5 1.7 1.1
Slc18a2 VMAT2 5-HT, DA, AE, adrenalin, histamine CNS aminergic 3.4 − −
Slc19a1 RFC Folate ubiquirous 3.4 1.3 1.4
Slc32a1 VIAAT Vesicular inhibitory Aas, GABA/Glycine CNS 3.4 − −
Slc25a40 − unknown ubiquitous, low levels 3.4 − −
Slc30a5 ZNT5 Zinc not brain or CP 3.4 2.0 1.9
Slc9a7 NHE7 sodium/hydrogen exchanger CP* 3.4 − −
Slc25a46 − unknown ubiquitous 3.3 1.2 1.0
Slc46a3 − unknown unknown 3.3 1.5 1.5
Slc4a2 AE2 Anion exchange CP* 3.3 2.7 2.9
(Continued)
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TABLE 3 | Continued
Gene ID Protein Transport function Distribution** A/E15 A/E19 A/P2
Slc5a6 SMVT Sodium-dependent multivitamin, biotin brain 3.2 1.7 1.5
Slc25a17 PMP34 peroxisomal membrane protein brain 3.1 1.6 1.5
Slc15a3 PHT2 di- and tri-peptides “faintly” in brain 3.1 − −
Slc12a4 KCC1 K+/Cl− CP* 3.1 2.2 2.0
Slc10a4 P4 Sodium/bile acid cotransporter brain (cholinergic neurons) 3.0 − −
Slc25a12 AGC1 L-glutamate, aspartate brain 3.0 1.9 1.8
Slc25a3 PHC Phosphate, mitochondrial brain 2.9 1.3 1.2
Slc26a3 DRA/CLD Chloride anion exchanger not brain or CP 2.9 − −
Slc25a4 ANT1 ADP/ATP brain 2.9 1.1 1.1
Slc15a2 PEPT2 Oligopeptides, antibiotics choroid plexus apical surface 2.8 0.7 0.8
Slc25a5 ANT2 ADP/ATP brain 2.8 1.2 1.2
Slc38a3 SNAT3 Sodium-coupled neutral amino acids not brain or CP 2.7 1.2 1.2
Slc25a14 UCP5 Brain mitochondrial carrier protein highest in brain and testis 2.7 1.6 1.4
Slc30a6 ZNT6 Zinc brain 2.7 1.3 1.1
Slc22a18 − Probably organic anions not brain or CP 2.6 1.4 1.6
Slc37a1 SPX1 Glycerol-3-phosphate ubiquitous 2.6 2.1 1.4
Slc25a35 − unknown unknown 2.6 − −
Slc33a1 ACATN1 Acetyl-coenzyme A brain 2.6 1.4 1.3
Slc36a1 PAT1 Neutral amino acids, glycine, proline, GABA brain 2.4 − −
Slc16a1 MCT1 Monocarboxylates ubiquitous 2.4 3.1 1.4
Slc20a1 PIT1 Sodium-dependent phosphate ubiquitous 2.4 1.7 2.0
Slc36a4 PAT4 Proton-coupled AAs, tryptophan, proline ubiquitous 2.3 − −
Slc48a1 HRG1 Heme transporter brain 2.3 1.9 1.3
Slc25a32 MFT Mitochondrial folate unknown 2.3 1.1 1.0
Slc41a1 MgtE Mg2+, other metal cations not brain or CP 2.3 a 1.7
Slc16a13 MCT13 Monocarboxylate not brain or CP 2.3 1.9 1.7
Slc26a4 PENDRIN Anions epithelial cells 2.2 − −
Slc16a2 MCT8 Monocarboxylate transporter 8, thyroxine brain 2.1 − −
Slc25a20 CACT Mitochondrial carnitine/acylcarnitine brain 2.1 1.1 0.9
Slc35b3 PAPST2 Adenosine 30-phospho 50-phosphosulphate ubiquitous 2.1 1.7 1.5
Slc7a10 ASC1 Asc-type amino acids, D-serine brain 2.1 0.6 0.8
Slc31a2 CTR2 Cu2+ ubiquitous − 1.7 1.0
For RNA-Seq) only transcripts with fold change (FC) > 2.0, p value < 0.05, and raw Illumina counts > 100 are shown. A comprehensive list with gene IDs and gene descriptions and
statistical data is in Table S2 of Supplementary Material. For microarrays: - : not on the array or not detected. a: absent in E19 samples. CP*: choroid plexus (Liddelow et al., 2013).
**Previously described tissue distribution from reviews in Hediger (2013). Note that in studies involving brain extraction it is often not stated if choroid plexuses were included or excluded.
microarray were generally consistent with those for RNA-Seq in
their developmental profile.
It is apparent from the above analysis that many genes
identified are from families involved in transport of ions
important for homeostatic mechanisms in the CSF and
interstitial fluid of the brain (Tables 2, 3, and Supplementary
Tables S2, S3). Themonovalent inorganic ion transporters known
to be functionally active in adult choroid plexus and involved
in CSF composition and secretion have been described in detail
and their expression levels correlated with functional data in the
paper by Liddelow et al. (2013). Divalent metal ions such as Ca2+,
Zn2+, and Mg2+ may be involved in specific cellular functions
in brain such a synaptic transmission of nerve impulses and are
considered briefly below.
The immunohistochemical data presented above indicate that
at least some of the most highly expressed Slc genes are able
to produce their protein products. A more difficult problem
is to establish the functional effectiveness of individual Slcs
for example for glucose, particular amino acids or specific
monocarboxylates. This is because of the overlap in substrates
between many SLCs (see Tables 2, 3). Because of this and of
upregulation of unaffected genes, even selective knockouts of
single genes may not reveal the contribution of that particular
gene to the transport of specific substrates (see Keep and Smith,
2011). However, it is possible to suggest that at least some of
the genes are indeed functionally more active in embryonic
choroid plexus by examining results of transport studies for
glucose, amino acids, monocarboxylates, and divalent cations in
developing brain.
Glucose Transport
The best known and ubiquitously distributed glucose transporter
Slc2a1 (GLUT1) was expressed at a 3-fold higher level in
the embryonic choroid plexus at transcript levels (Table 4)
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TABLE 4 | Glucose and Monocarboxylate transporters in developing rat choroid plexus.




Slc5a10 Slc family 5, sodium/glucose cotransporter 10 E 62 0
Slc2a3 Slc family 2, facilitated glucose transporter 3, GLUT3 E 150 8
Slc2a4 Slc family 2, facilitated glucose transporter 4, GLUT4 E 90 6
Slc35d2 UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose 5.1 224 25
Slc45a1 Proton-associated sugar transporter A, glucose E 33 5
Slc2a1 Slc family 2, facilitated glucose transporter 1, GLUT1 3.0 368 111
Adult A/E
Slc2a12 Slc family 2, facilitated glucose transporter 12, GLUT12 5.1 3569 10437
Slc2a5 Slc family 2, facilitated glucose transporter 5, GLUT5 2.3 20 27
Klf15 Krueppel-like factor 15, regulator of GLUT4 2.2 292 373
MONOCARBOXYLATE TRANSPORTERS
Embryo E/A
Slc16a10 Monocarboxylate transporter 10, MCT10, TAT1, T3, T4 E 3089 51
Adult A/E
Slc16a8 Monocarboxylate transporter 3, MCT3 55 49 1524
Slc16a6 Monocarboxylate transporter 7, MCT6, MCT7 3.7 1524 3239
Slc16a1 Monocarboxylate transporter 1, MCT1 2.4 577 1235
Slc16a7 Monocarboxylate transporter 2, MCT2 2.3 44 58
Slc16a13 Monocarboxylate transporter 13, MCT13-human 2.3 1354 1756
Slc16a2 Monocarboxylate transporter 8, MCT8-human, thyroid hormone 2.1 7599 9323
RNA-Sequencing expression levels of glucose and monocarboxylate transporters in the E15 and adult rat lateral ventricular choroid plexus. Fold change data obtained from normalized
data and refer to expression change compared to opposite age. Raw count data have not been normalized and thus the calculated fold changes EC may be different from E/A raw
count ratios. E is embryo only. A is adult only.
suggesting that it would have significant functional activity at
both ages, although higher in the embryo. It has been identified
in developing choroid plexus in a number of previous studies
(Vannucci, 1994; Baud et al., 2003); the level was highest during
gestation followed by a 50% decline by P1 and a further decline
during the first postnatal week (Bauer, 1998). Bauer (1998)
suggests this reflects a decline in cerebral glycogen content (Kohle
and Vannucci, 1977). Glycogen is particularly prominent in
choroid plexus epithelial cells in the late embryonic and early
neonatal period, after which it disappears (Schachenmayr, 1967
and see Netsky and Shuangshoti, 1975). Slc2a3 (GLUT3) in the
present study was expressed only at E15 in RNA-Seq compared
to adult and in microarray was below adult at E19 and P2. The
protein product of this gene was not identified in a previous
study of postnatal rat choroid plexus (Vannucci, 1994). Slc2a4
(GLUT4) was also expressed only in the embryo, although at a
low transcript count (90). This appears to be consistent with the
finding of Vannucci et al. (2000) in mouse choroid plexus where
it was detected as early as at E14. In addition, in the present study
Slc5a10 (SGLT5), a sodium-glucose transporter was expressed
exclusively in the embryonic choroid plexus. Previously it has
only been identified in kidney cortex (Wright, 2013). However,
the raw transcript count for this gene was low, thus its functional
significance is unclear.
Monocarboxylate Transport
It has been long accepted that although glucose is a
fundamentally important energy substrate in the brain,
during development the brain also uses lactate and other
monocarboxylates to a substantial degree. In the postnatal period
in rodents it has been suggested that a switch occurs from a
combination of glucose, lactate, and ketone body metabolism in
the immature brain to a reliance on glucose in the adult (Cremer,
1982; Nehlig, 1997). Several monocarboxylate transporters have
been found in the developing brain of rodents. Slc16a1 (MCT1)
is expressed and its protein product present in cerebrovascular
endothelial cells of rodents at higher levels in early postnatal ages
compared to later (Leino et al., 1999; Vannucci and Simpson,
2003). In contrast the level of Slc16a7 (MCT2) expression and
protein product, present predominantly in neuronal cells, do not
appear to be developmentally regulated (Vannucci and Simpson,
2003). Slc16a1 (MCT1), but not Slc16a7 (MCT2), has been
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TABLE 5 | Expression of amino acid transporters in embryonic (E15) and adult rat choroid plexus.




Slc38a5 Sodium-coupled neutral amino acid transporter 5, glycine E 1021 6
Slc43a3 Putative transporter (by similarity) E 914 8
Slc7a11 Solute carrier family 7 (cationic amino acid transporter, y+ system), member 11 44 13298 178
Slc43a1 Large neutral amino acids transporter small subunit 3 E 204 5
Slc7a1 High affinity cationic amino acid transporter 1 16 7273 264
Slc38a1 Sodium-coupled neutral amino acid transporter 1, glutamine 15 1188 47
Slc6a6 Sodium- and chloride-dependent taurine transporter 14 813 33
Slc6a15 Orphan sodium- and chloride-dependent neurotransmitter transporter NTT73 14 5446 227
Slc7a3 Cationic amino acid transporter 3, l-lysine, l-ornithine, l-arginine 9.1 42.0 2.7
Slc38a4 Sodium-coupled neutral amino acid transporter 4 5.2 102 11
Slc1a4 Neutral amino acid transporter A, l-serine, l-alanine, l-cystine, l-proline, 5.1 436 49
Slc1a3 Excitatory amino acid transporter 1, l-glutamate transport, malate-aspartate 4.5 4372 577
Slc7a2 Low affinity cationic amino acid transporter 2, l-arginine, l-lysine, l-ornithine 2.7 179 38
Slc38a7 Putative sodium-coupled neutral amino acid transporter 7 2.7 337 73
Slc43a2 Large neutral amino acids transporter small subunit 4 2.4 651 156
Slc1a5 Neutral amino acid transporter B(0) l-serine, 2.1 1119 308
Adult A/E
Slc6a20 Sodium- and chloride-dependent transporter XTRP3, proline IMINO transporter 24 44 594
Slc6a11 Sodium- and chloride-dependent GABA transporter 3 5.0 10 28
Slc3a1 Neutral and basic amino acid transport protein rBAT 4.5 746 1936
Slc7a4 Cationic amino acid transporter 4 4.0 706 1618
Slc38a3 Sodium-coupled neutral amino acid transporter 3. l-asparagine, l-glutamine, l-histidine 2.7 4507 6922
Slc36a1 Proton-coupled neutral amino acid transporter 1, l-glycine, l-proline 2.4 97 136
Slc36a4 Proton-coupled amino acid transporter 4 2.3 718 969
Slc7a10 Asc-type neutral amino acid transporter 1, d-serine, l-serine 2.1 783 935
Expression levels of glucose and monocarboxylate transporters E15 and adult lateral ventricular choroid plexus. RNA-Seq analysis. Fold change (FC). Raw counts are transcript counts
from original data. Raw count data have not been normalized and thus the calculated fold changes FC may be different from E/A raw count ratios. E is embryo only. Data on blood-brain
amino acid transport in neonatal and adult brain. Rat: (Sershen and Lajtha, 1976; Baños et al., 1978; Lefauconnier and Trouvé, 1983; Benrabh and Lefauconnier, 1996); blood-CSF
transport, (Al-Sarraf et al., 1995, 1997; Al-Sarraf, 2002). Rabbit: (Braun et al., 1980; Cornford et al., 1982; Cornford and Cornford, 1986). Data on blood-brain amino acid transport in
adult brain. (Davson and Segal, 1996; Segal, 2001).
identified in adult mouse choroid plexus (Koehler-Stec et al.
(1998).
The expression of monocarboxylate transporters appears to
have been less studied in the embryonic brain barrier interfaces.
Apart from a high expression of Slc16a10 (MCT10) in embryonic
mouse choroid plexus (Liddelow et al., 2012) nothing seems to
be known about monocarboxylate transporters in the embryonic
choroid plexus. This high expression in embryonic mouse
choroid plexus is confirmed in the present study for embryonic
rat choroid plexus. This is a particularly noteworthy finding
because MCT10 is a transporter for tri-iodothyronine, T3 and
thyroxine, T4 (Porterfield and Hendrick, 1992), which are
essential for normal brain development. Inadequate delivery of
T4 to the developing brain, usually due to iodine deficiency,
results in cretinism (Rivas and Naranjo, 2007; Skeaff, 2011).
Given the prominence of the choroid plexuses in the embryonic
brain compared to vascularisation (Johansson et al., 2008), it may
be that MCT10 in the choroid plexuses along with TTR, a thyroid
hormone carrier highly expressed throughout development, is
themajormechanism by which thyroxine is delivered to the brain
in early stages of its development. This is also in line with the low
developmental expression of Slco1c1, the main thyroid hormone
transporter expressed at the blood-brain interfaces in the adult
(Kratzer et al., 2013).
Published data demonstrating at the protein level, that some
of the glucose transporters (Vannucci, 1994; Bauer, 1998; Baud
et al., 2003) and monocarboxylate transporters (Leino et al.,
1999; Vannucci and Simpson, 2003) are present in the choroid
plexus barrier interface between blood and CSF in the developing
brain indicate that these transporters are probably functional.
In addition, it has been shown that brain uptake of both
glucose (Braun et al., 1980; Cornford and Cornford, 1986)
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TABLE 6 | Expression of zinc and other metal transporters in embryonic (E15) and adult rat choroid plexus.




Slc30a2 Zinc transporter 2, ZnT2 E 608 8
Slc39a8 Zinc transporter ZIP8 37 1493 24
Slc30a10 Zinc transporter 10, ZnT8, ZnT10 E 224 4
Slc39a10 Zinc transporter, 10 (Predicted), ZIP10 2.5 5547 1304
OTHER METALS
Sfxn1 Sideroflexin-1, iron transport 14 1103 45
Slc11a1 Natural resistance-associated macrophage protein 1, Mn+, Cd+ transporter E 130 8
Heph Hephaestin, iron, copper transport E 67 5
Slc34a2 Sodium-dependent phosphate transport protein 2B 6.1 107 10
LOC100360087 Ferritin light chain 1-like, iron transport 3.6 837 132
Tfrc Transferrin receptor protein 1 3.1 1354 258
ADULT
ZINC A/E
Slc39a1 ZIP1, zinc transport 12 2143 17839
Slc39a12 Zinc transporter ZIP12 12 489 3318
Slc30a4 Zinc transporter 4, ZnT4 4.5 2025 5248
Slc39a13 Zinc transporter ZIP13 3.9 758 1681
Slc30a3 Zinc transporter 3, ZnT3 3.8 54 117
Slc30a5 Zinc transporter 5, Co, ZnT5 3.4 1397 2719
Slc30a6 Zinc transporter 6, Co, ZnT6 2.7 491 752
OTHER METALS
Tf Transferrin, iron transport 183 2027 212407
Lcn2 Lipocalin 2, Signal recognition particle receptor subunit beta, iron transport 55 12 365
Cp Ceruloplasmin copper transport 6.2 188 675
Slc31a1 High affinity copper uptake protein 1 4.6 6673 17839
Slc20a1 Sodium-dependent phosphate transporter 1 2.4 2155 2919
Slc41a1 MgtE-like magnesium transporter, member 1 2.3 401 530
NO CHANGE WITH AGE
ZINC
Slc30a1 ZNT1, zinc transport - 1048 843
Slc30a6 ZNT6, zinc transport - 491 752
Slc30a7 ZNT7, zinc transport - 424 400
Slc30a9 ZNT9, zinc transport - 1512 1526
Slc39a3 ZIP3 zinc transport - 322 315
Slc39a4 ZIP4, zinc transport - 58 38
Slc39a5 ZIP5, zinc transport - 233 172
Slc39a6 LIV1, zinc transporter - 1819 1241
Slc39a7 ZIP7, zinc transporter - 4792 4670
Slc39a9 ZIP9, zinc transporter - 798 540
Slc11a2 DMT1, divalent ion transport, including iron - 1929 1518
OTHER METALS
Slc40a1 iron-regulated transporter - 889 455
Slc31a2 CTR2, copper transport - 63 144
Slc41a2 magnesium transporter - 20 63
Expression levels of Zn and other metal transporters comparing E15 embryo and adult lateral ventricular choroid plexus obtained from RNA-Seq analysis. Fold change (FC), Embryo
only (E). Raw counts are transcript counts from original data. Raw count data have not been normalized and thus the calculated fold changes FC may be different from E/A raw count
ratios.
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FIGURE 4 | Immunohistochemistry of influx transporters in
sagittal and coronal sections from E15 and adult rat choroid
plexus: SLC 16a10 (A,A1,B), SLC 1a3 (C,C1,D), and SLC 5a5
(E,E1,F). The rectangles in (A,C,E) from E15 are shown at higher
magnification in A1,C1,E1. For comparison adult choroid plexus
stained for the same three transporters is shown in B,D,F. Note the
differences in distribution of immunoreactivity between E15 stained for
the three different transporters and between E15 and adult choroid
plexus stained for a given transporter. (A) The rostral-most leaflet of
the lateral ventricular choroid plexus facing the ganglionic eminence
(GE) demonstrates a very strong reactivity in contrast to the
caudal-most leaflet facing the developing hippocampus (HIP). (A1) At
higher magnification the Immunostaining fills the entire cytoplasm
apical to the nuclei (N) and down along the basolateral membrane
(arrowheads) just sparing the empty glycogen space in the epithelial
cells of the rostral leaflet. The caudal leaflet is also positively stained
and shows a more uniform cytoplasmic reactivity although condensed
at the perinuclear membrane. (B) Adult choroid plexus shows virtually
no immunostaining for SLC 16a10. (C) Both leaflets of the choroid
plexus demonstrate a uniform cytoplasmic immunoreactivity for SLC
1a3 although not as strong as that of the adjacent dentate
neuroepithelium (DN). (C1) At higher magnification the immunostaining
of the entire plexus shows a pattern similar to that described for
the rostral leaflet stained for SLC 16a10 (compare with A1). (D)
Adult choroid plexus shows virtually no immunostaining for SLC 1a3.
(E) The E15 choroid plexus shows very little immunoreactivity
following staining for SLC 5a5 which on the other hand outlines the
CSF surface of the hippocampus. (E1) At higher magnification a
weak Immunostaining is localized to some basolateral cell membranes
(arrowheads) of the choroid plexus epithelial cells. (F) Adult choroid
plexus epithelial cells exhibit a uniform very fine granular cytoplasmic
reactivity following immunostaining for SLC 5a5. Many cells also
exhibit a coarse granular staining (open arrows) and apical membrane
reactivity (open arrowheads). (A,C,E) Same magnification, scale bar
500µm. (A1,C1,E1) Same magnification, scale bar 50µm. (B,D,F)
Same magnification, scale bar 100µm.
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and lactate (Cornford et al., 1982; Cornford and Cornford,
1986) is greater in newborn rabbits than in adults, which again
supports the likelihood that transporters for these metabolically
important nutrients are indeed functionally more active in the
developing brain. It is not clear from the transport studies, which
specific glucose transporters would have been involved, but the
transcript numbers perhaps give some indication of the relative
functional importance of the different transporters. The most
highly expressed glucose transporter at both ages was Slc2a12,
although 5 fold more in the adult.
The finding in the present study of a high expression
of glucose transporters in the embryonic brain, but not of
those transporting lactate and other monocarboxylates, suggests
that the embryonic brain is like the adult brain in being
exclusively dependent on glucose metabolism as a source of
energy, as suggested previously by Vannucci and Vannucci
(2000) and unlike the postnatal brain in which monocarboxylate
transport should be functionally significant. However, of all
the monocarboxylate transporters detected on the arrays, three
genes, Slc16a3, Slc16a4 (not detected by RNA-Seq) and Slc16a10,
were expressed at a higher level at E19 than at P2 and adult,
and the others were expressed at a higher level in adult.
It is possible that a transient up-regulation occurs later in
post-natal development for some of these transporters. This
was shown for Slc16a1 (MCT1) in the postnatal period at
least in rodents, and may relate to the high fat content in
human and rodent maternal milk, which generates substantial
ketone body concentrations in blood, as a consequence of
liver metabolism (Vannucci and Vannucci, 2000; Vannucci and
Simpson, 2003).
Amino Acid Transport
There is a limited amount of information concerning the
effectiveness of amino acid transport in vivo, that could support
expression data. Experiments mainly carried out in the 1970s-
80s were mostly performed in neonatal rats (e.g., Baños et al.,
1978; Lefauconnier and Trouvé, 1983, see Table 6) but some
were in fetal and postnatal rabbits (Braun et al., 1980; Cornford
et al., 1982; Cornford and Cornford, 1986). Very few of these
studies estimated amino acid entry from blood into CSF. Most
studied brain tissue; an exception is the papers of Al-Sarraf and
colleagues (Al-Sarraf et al., 1995, 1997; Al-Sarraf, 2002). However,
given the paucity of blood vessels in very immature brain it
is likely that much of the amino acid detected in brain tissue
of, for example neonatal rodent, arrived there via the choroid
plexuses and CSF. Another interpretational difficulty is that these
experiments were done before data on individual transporters
were available. Thus, at best we can only compare individual or
classes of amino acids shown to be transported in vivo in the
developing brain with the various families of SLC transporters
known to transport individual or classes of amino acids (Table 5).
However, the finding (described in the papers cited above)
that transport of many amino acids in developing brain is
greater than in the adult strongly supports the proposition
that the higher expression of many amino acid transporters in
the developing brain is indeed reflected in greater transport
activity.
Metal Transport
Both of the major zinc transporter families (Slc30, ZnT and Slc39,
ZIP) are represented in our two datasets. The members of the
two families function in opposite directions, thus maintaining
cellular zinc homeostasis. ZnT proteins of Slc30 gene eﬄux zinc
whereas ZIP proteins function to increase zinc uptake when
cellular zinc is depleted (Marger et al., 2014; Tepaamorndech et
al., 2014). In the context of transfer of zinc across the epithelial
cells of the choroid plexus it may be that they operate in tandem.
Support for this comes from the observation that SCL39A6 (LIV-
1) has been immunolocalised to the apical membrane of the
neonatal choroid plexus epithelial cells (Chowanadisai et al.,
2005).
None of the six Slc30 genes identified in this study (two high
in the embryo, Slc30a2, Slc30a10, and four in the adult, Slc30a3-
6, 2.7–4.5 FC) have previously been reported in choroid plexus.
Of the three Slc39a genes identified (Slc39a8, 37 FC higher in
embryo; Slc39a12 and Slc39a13, FC 12 and 3.9 higher in adult,
respectively) none appear to have been identified previously in
choroid plexus. The microarray data show that Slc30 and Slc39
genes identified in E15, but not in adult, are still expressed at the
perinatal stages. Other genes of these families whose expression
is lower at E15 display a rapid developmental increase in
expression, to reach adult level shortly after birth. Altogether this
suggests that choroidal zinc transport is substantial throughout
development.
Zinc is an essential nutrient for many cellular biochemical
processes (Tyszka-Czochara et al., 2014) and is essential for
normal brain development and function (Sandstead, 1985). The
requirement for zinc is increased during embryonic development
and deficiency results in birth defects (McKenzie et al., 1975;
Sandstead et al., 1975), including multiple defects in neuronal
development, by mechanisms that are unclear (Chowanadisai
et al., 2013a; Grabrucker et al., 2014). Slc39a12 (ZIP12) has been
found to be highly expressed in brain of human andmouse adults
and in development appears to be involved in early stages of
neuronal differentiation and neurite outgrowth, through its role
as a zinc transporter (Chowanadisai et al., 2013a,b). Zinc has
specific functions in synaptic transmission. 5–15% of the brain’s
zinc content is concentrated in synaptic vesicles of glutamatergic
neurons. This is of importance for neuronal function in the
developing and adult brain, but the identification of several genes
for glutamate receptors and other transmitters, as reported earlier
(Liddelow et al., 2013) suggests that the zinc transporters in
choroid plexus may have a function in relation to the innervation
of the choroid plexus. A more general consideration of the
importance for neural function in the brain is outside the
scope of this paper. Finally, zinc transporters, like other metal
transporters, may transport this metal for use by the epithelial
cells themselves, as discussed below.
Iron uptake into the brain occurs across both the blood-brain
and blood-CSF barriers (Moos and Morgan, 2000). Transferrin,
which binds iron, makes an important contribution at both
interfaces, but there are some differences in the mechanisms
involved. At the blood-brain barrier, transferrin receptors on the
cerebral endothelial cells bind transferrin-carrying iron, which
is taken up into the cells. This mechanism and subsequent
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steps in iron delivery to the brain have been described in
detail (e.g., Leitner and Connor, 2012; Singh et al., 2014) and
will not be considered further here. However, the uptake of
both iron and transferrin is greater in the developing brain,
the more so for iron itself (Morgan and Moos, 2002). The
involvement of the choroid plexuses in iron transport into the
brain in addition to transferrin uptake via transferrin receptors
also involves the synthesis and secretion of transferrin into
the CSF (Leitner and Connor, 2012). In the adult brain it
has been suggested that the choroid plexuses, compared to
the cerebral vasculature may play a much larger role in iron
uptake than previously thought (Rouault et al., 2009). As
mentioned above in relation to other transport properties, the
early development of the choroid plexuses compared to brain
vasculature (Johansson et al., 2008) indicates that the plexuses
are likely to be even more important for iron transport in the
developing brain. The likely importance of the transferrin gene,
Tf, for iron transport in both the embryonic and adult choroid
plexus is emphasized by the high transcript numbers (Table 6),
although much higher in the adult (183 fold). Tf expression
however increases rapidly, and is only 5- and 2.3 times lower
at E19 and P2 respectively than in adult. Several other iron
transporters were expressed at a higher level in the embryo than
in the adult: sideroflexin-1, Sfxn1 and ferritin light chain 1-like
(LOC100360087), but in terms of transcripts both were expressed
at lower levels than Tf (Table 6). Slc11a1 and hephaestin were
only expressed in the embryonic plexus but at low levels, so their
functional contribution is doubtful. The transferrin receptor was
expressed at a higher level in embryonic choroid plexus (Table 6)
but this was reversed at birth. Several studies have described
developmentally regulated immunohistochemical staining for
several of the iron transporters in the choroid plexus (e.g.,
Siddappa et al., 2003; Wang et al., 2008). Moos and Morgan
(1998) have provided direct evidence for the transfer of 59Fe
from blood into brain and CSF. The importance for iron in brain
function lies in its involvement in cellular respiration and cell
proliferation during development. The brain also requires iron
for myelination and neurotransmission (Leitner and Connor,
2012).
Manganese (Mn) is an essential biological element and a
necessary cofactor in a number of important enzymatic reactions
(Gunter et al., 2013) and is an essential micronutrient for normal
brain development (Santamaria and Sulsky, 2010). Manganese
transport has been demonstrated in choroid plexus freshly
isolated from P2 and adult rats; uptake into plexus cells was found
to be greater in P2 choroid plexuses. Unidirectional blood-to-
CSF transport of manganese was demonstrated using P2-derived
in vitro reconstituted epithelium (Schmitt et al., 2011). As these
authors point out it is not possible to link this transport to specific
transporters but suggest the divalent metal transporters SLC11a2,
SLC11a3, SLC39a8, and SCL39a14 as potential candidates. In
the RNA-Seq and array screens in the present study Slc11a1
(8.9 fold) and Slc39a8 (37 fold) were expressed at higher
levels in the embryonic and perinatal choroid plexus, which
correlated with the higher uptake shown by Schmitt et al.
(2011). In addition, transport of manganese by transferrin has
been demonstrated (Gunter et al., 2013). Copper is an essential
nutrient for normal growth and development of the fetus and
neonate (Uriu-Adams et al., 2010). It is a co-factor for several
enzymes and also a structural component with involvement
in many physiological pathways in the brain; in particular
it is a component of cytochrome c oxidase, a member of
the super-family of heme-copper-containing oxidases (Scheiber
et al., 2014). In addition to divalent ion transporters thought
to transport copper that were identified in the present study
(e.g., Slc11a2) at least two more specific copper transporters were
expressed in the choroid plexus. Ceruloplasmin was expressed
at modest transcript numbers some 6.2 fold higher in the adult
plexus (Table 6). The high affinity copper transporter, Slc31a1,
was amongst the highest expressed transporter genes at both
ages identified in this study and was 4.6 fold higher in the adult
(Table 6). These data are in accordance with in situ hybridization
showing the expression of Slc31a1 in choroid plexus and its
rapid, choroid plexus-restricted increase from E14 to E18.5 in
mice (Kuo et al., 2001). These authors suggest that the choroid
plexus is a major pathway of copper supply to the developing
brain.
Thus, genes for all of the main metal transporters have
been identified in the choroid plexus, several of them expressed
at higher levels in the embryo than in the adult, presumably
reflecting the importance of their involvement in brain
development. Metals are also needed for normal choroidal
epithelial functions. Iron-containing cytochrome levels are high
in choroid plexus as a result of high mitochondrial activity.
Copper, zinc, and manganese are cofactors of several enzymatic
systems, in particular superoxide dismutases (SOD) involved in
regulating oxidative stress. Both Mn-SOD and Cu-Zn-SOD are
well expressed in choroid plexus throughout development (Yon
et al., 2008, 2011). Thus, a primary function of metal transporters
in the choroid plexus may be to supply metals required for proper
functioning of the blood-CSF barrier. Of note, copper deficiency
leads to a specific increase in Slc31a1 expression at the choroid
plexus, a finding interpreted as a compensatory mechanism to
spare the choroid plexus itself from copper deficiency (Gybina
and Prohaska, 2006).
Immunohistochemistry
The protein products and their cellular distribution were
demonstrated in E15 and adult choroid plexus for a
selection of the Slcs identified in the gene screens, using
immunohistochemistry. Three patterns of immunostaining
were identified in E15 plexus epithelial cells: (i) differential
immunoreactivity with regional distribution (e.g., SLC16a10),
(ii) strong immunoreactivity with uniform distribution
(SLC1a3), and (iii) weak immunoreactivity with uniform
distribution (SLC5a5). In the adult plexus two different
patterns of immunoreactivity in epithelial cells were noted:
(i) strong immunoreactivity (SLC5a5) and (ii) weak or lack of
immunoreactivity (SLC1a3, SLC16a10, SLC39a4). In a previous
study (Liddelow et al., 2013) we illustrated immunostaining for
SLC4a1 that was strong and uniformly distributed in E15 rat
choroid plexus. Immunostaining for AQP1 has also been shown
to have a uniform cellular distribution which was strong in E15
rat choroid plexus with characteristic localization in the apical
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TABLE 7 | Comparison of expression level (transcript numbers) and immunostaining for protein gene product.
Gene ID Protein ID E15 transcript raw counts E15 immunostaining Adult transcript raw counts Adult immunostaining
Slc16a10 MCT10 3089 Strong, regional 51 Weak, uniform
Slc38a5 SNAT5 1021 Moderate, uniform 6 Minimal, few patches
Slc4a1 AE1* 7109 Strong, uniform 70 Minimal-absent
Slc11a1 NRAMP 130 Moderate, uniform 8 Absent
Slc1a3 EAAT1 4372 Strong, uniform 577 Weak, uniform
Slc5a5 NIS 163 Weak, uniform 4916 Strong, uniform
Slc39a4 ZIP4 58 Weak, uniform 38 Apical, membrane
Aqp1 AQP1** 20112 Strong, uniform 32149 Very strong, uniform
Uniform indicates all cells were positive. Regional indicates staining confined to only some (contiguous) cells.
* from Liddelow et al. (2013), ** from Johansson et al. (2005).
membrane of all epithelial cells with weaker staining in the
basolateral membrane; in the adult plexus the immunostaining
was even stronger (Johansson et al., 2005). There was good
correspondence between gene expression level and strength of
protein immunostaining (Table 7).
Limitations of Study
There are several limitations in this study. One concerns the use
of whole choroid plexus tissue. However, as discussed previously
(Liddelow et al., 2013) the epithelium is the predominant cell
type, representing up to 90% of the plexus tissue (Keep and
Jones, 1990; Liddelow et al., 2012). The absence of transcript
for Cldn5 (a brain barrier cerebral endothelial-specific claudin
family member) in the current RNA-Seq dataset suggests that
any possible contamination is below detectable limits (Liddelow
et al., 2013). The immunohistochemical evidence in that paper
and in the current study for a range of protein products of
the genes identified in the choroid plexus samples showed
that these proteins were largely confined to the epithelial
cells of the plexus. The analysis of large RNA sequencing
databases is still quite new and relies on the accuracy of the
annotations for each species studied. The rat genome is well
annotated and the number of unknown genes is very low,
however, there is still the possibility that some transcripts
were missed. The papers based on microarray studies of adult
mouse choroid plexus (Marques et al., 2011 and Janssen
et al., 2013) on adult human and mouse adult choroid plexus
provide important additional data on gene expression in the
choroid plexuses of other species. These together with that of
Liddelow et al. (2012) a mouse microarray study and that of
Ek et al. (2015) an RNA-Seq study in primate choroid plexus
provide comprehensive datasets for interspecies comparison
reviews; however, this is outside the scope of this research
paper.
We did not attempt to analyze all functional groups
represented in the transcriptomic dataset. For example Slc16a10
showed strikingly high expression (Table 4) exclusively in
the embryo; it has been included primarily because it is
a monocarboxylate transporter (MCT10) although its little
investigated putative function as a thyroid hormone transporter
may well prove to be more functionally important. This high
expression in the embryonic choroid plexus is in striking contrast
to the expression of the best-known thyroxine transporter,
Slc16a2, which barely changed expression during development.
Another limitation is that, as pointed out above, expression
data alone do not necessarily equate to functional activity. The
immunohistochemical evidence in this paper, in Liddelow et al.
(2013) and in earlier reports summarized in the Discussion
shows that at least some of the mRNAs are being translated
to protein. The summary of in vivo physiological transport
studies for glucose, amino acids, monocarboxylates and metals
in developing brain show a good correlation with the level of
expression of relevant transporter genes, although because of
overlap and redundancy it is generally not possible to pinpoint
the specific contribution of any one gene.
Conclusions
The results from this study and two earlier ones on gene
expression in embryonic and adult rat choroid plexus (Kratzer
et al., 2013; Liddelow et al., 2013) as well as a study of embryonic
and adult mouse choroid plexus (Liddelow et al., 2012) show that
a very large number of transporter genes are expressed in the
embryonic lateral ventricular choroid plexuses as early as E15
which is only a day after these plexuses appear in the rat brain
(Johansson et al., 2005). In the present study 64% of all the 389
known SLC transporters, with representatives of all but 4 of the
52 SLC families, were identified. Many of these were expressed
at higher or similar levels in the embryonic compared to the
adult plexus. This suggests that the lateral ventricular choroid
plexuses make an important contribution to supply of nutrients
and micronutrients to the brain early in development. This
conclusion is supported by the results of immunohistochemistry
for a number of the protein products of genes expressed in the
embryonic and adult choroid plexus (Figure 4), as well as data
from published transport studies for glucose, monocarboxylates,
amino acids and divalent metals summarized in the Discussion.
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